SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-008510
Filing Date
2023-03-16
Accepted
2023-03-16 16:44:49
Documents
7
Period of Report
2023-05-03

Document Format Files

Seq Description Document Type Size
1 DEF 14A def_proxy_agm_2023_15_03.htm DEF 14A 1733811
2 COURTESY COPY OF DEF_PROXY_AGM_2023_15_03 itrm-def_proxy_agm_2023_15_0.pdf DEF 14A 59460
3 GRAPHIC img156636897_0.jpg GRAPHIC 4586
4 GRAPHIC img156636897_1.jpg GRAPHIC 2403
5 GRAPHIC img156636897_2.jpg GRAPHIC 11646
6 GRAPHIC img156636897_3.jpg GRAPHIC 4577189
7 GRAPHIC img156636897_4.jpg GRAPHIC 787835
  Complete submission text file 0000950170-23-008510.txt   9231342
Mailing Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24
Business Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38503 | Film No.: 23739464
SIC: 2834 Pharmaceutical Preparations